VJNeurology is committed to improving our service to you

Share this video  

VJNeurology is committed to improving our service to you

EAN 2020 | BKCa channels: potential novel anti-migraine target

Messoud Ashina • 29 May 2020
EAN 2020
Headache
Perspectives Treatment

Messoud Ashina, MD, PhD, DMSc, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark, discusses whether direct Large-conductance calcium-activated potassium (BKCa) channel activation can provoke migraine in migraine patients, and whether the BKCa channel could be a potential novel target for its treatment.. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).

More from Messoud Ashina

1:47
Anti-CGRP monoclonal antibodies for difficult to treat migraines: DELIVER trial
Messoud Ashina • 23 Jun 2022
2:43
The burden of migraine: from individuals to society
Messoud Ashina • 23 Jun 2022
3:19
Real-world studies show effectiveness of anti-CGRP mAbs in difficult to treat patients with migraine
Messoud Ashina • 23 Jun 2022
3:29
The evolving migraine prevention landscape: EAN 2020 highlights
Messoud Ashina • 29 May 2020

Related Videos

5:45
New European Academy of Neurology guidelines for cluster headache treatment
Rigmor Hojland Jensen • 19 Oct 2023
1:36
New cluster headache treatments are needed to better meet the needs of patients
Rigmor Hojland Jensen • 19 Oct 2023
3:17
Diagnostic criteria for trigeminal autonomic cephalalgias
Elizabeth Leroux • 18 Oct 2023
2:25
Challenges facing trigeminal autonomic cephalalgia diagnosis
Elizabeth Leroux • 18 Oct 2023
The content of VJNeurology is intended for healthcare professionals